Cognition Therapeutics Inc

General ticker "CGTX" information:

  • Sector: Health Care
  • Industry: Pharmaceuticals
  • Capitalization: $18.4M

Cognition Therapeutics Inc does not follow the US Stock Market performance with the rate: -35.8%.

Estimated limits based on current volatility of 16.9%: low 0.54$, high 0.76$

Factors to consider:

  • Current price 37.5% below estimated low
  • Earnings for 9 months up through Q3 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [0.98$, 2.52$]
  • 2024-12-30 to 2025-12-30 estimated range: [1.04$, 2.62$]

Financial Metrics affecting the CGTX estimates:

  • Negative: Non-GAAP EPS, $ of -0.86 <= 0.10
  • Negative: Operating profit margin, % of -100 <= 1.03
  • Negative: Operating cash flow per share per price, % of -25.50 <= 2.35
  • Positive: Industry inventory ratio change (median), % of -2.41 <= -0.39
  • Negative: negative Net income

Similar symbols

Short-term CGTX quotes

Long-term CGTX plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $28.60MM $43.55MM $50.72MM
Operating Income $-28.60MM $-43.55MM $-50.72MM
Non-Operating Income $16.94MM $22.15MM $24.94MM
Interest Expense $0.89MM $0.03MM $0.00MM
R&D Expense $18.57MM $30.32MM $37.20MM
Income(Loss) $-11.66MM $-21.40MM $-25.79MM
Profit(Loss) $-11.66MM $-21.40MM $-25.79MM
Stockholders Equity $51.27MM $40.25MM $24.47MM
Inventory $1.99MM $0.00MM $0.00MM
Assets $59.14MM $50.42MM $35.16MM
Operating Cash Flow $-3.63MM $-18.53MM $-16.02MM
Capital expenditure $0.03MM $0.17MM $0.15MM
Investing Cash Flow $-0.03MM $-0.17MM $-0.15MM
Financing Cash Flow $53.20MM $5.55MM $4.52MM
Earnings Per Share* $-0.46 $-0.03 $-0.86

* EPS are Split Adjusted, recent splits may be reflected with a delay.